CD38 is methylated in prostate cancer and regulates extracellular NAD+
DOI: 10.1186/s40170-018-0186-3
Andrea Sboner,
Andrew S. Goldstein,
Angelo M. De Marzo,
David A. Elashoff,
David Esopi,
Elizabeth A. Platz,
Himisha Beltran,
Jack Mottahedeh,
Matthew B. Rettig,
Michael A. Teitell,
Michael C. Haffner,
Preston D. Crowell,
Rohan Bareja,
Srinivasan Yegnasubramanian,
Takao Hashimoto,
Tristan R. Grogan,
William B. Isaacs
Keywords: Prostate, CD38, NAD+, Methylation
Abstract:
The online version of this article (10.1186/s40170-018-0186-3) contains supplementary material, which is available to authorized users
Full-Text
